Jeroen Cant

Jeroen Cant

Auto-generated profile, based on publicly available information

Jeroen Cant

Agfa NV, Radiology Solutions R&D Septestraat 27 2640 Mortsel Belgium

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2025 in Journal of Medical Economics
Verified
Journal Article
Open access
LML. Maas
L. Maas
CCC. Contreras-Meca
C. Contreras-Meca
SGSamuele Ghezzo
Samuele Ghezzo
FBF. Belmans
F. Belmans
ACAndrea Corsi
Andrea Corsi
JRJavier del Riego
Javier del Riego
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the third most common cause of cancer-related death. Cirrhosis is a major contributing factor, accounting for over 90% of HCC cases. With the high mortality rate of HCC, earlier detection of HCC is critical. When added to magnetic resonance imaging (MRI), artificial intelligence (AI) has been shown to improve HCC detection. Nonetheless, to date no cost-effectiveness analyses have been conducted on an AI tool to enhance earlier HCC detection. This study reports on the cost-effectiveness of detection of liver lesions with AI improved MRI in the surveillance for HCC in patients with a cirrhotic liver compared to usual care (UC). The model structure included a decision tree followed by a state-transition Markov model from an Italian healthcare perspective. Lifetime costs and quality-adjusted life years (QALY) were simulated in cirrhotic patients at risk of HCC. One-way sensitivity analyses and two-way sensitivity analyses were performed. Results were presented as incremental cost-effectiveness ratios (ICER). For patients receiving UC, the average lifetime costs per 1,000 patients were €16,604,800 compared to €16,610,250 for patients receiving the AI approach. With a QALY gained of 0.55 and incremental costs of €5,000 for every 1,000 patients, the ICER was €9,888 per QALY gained, indicating cost-effectiveness with the willingness-to-pay threshold of €33,000/QALY gained. Main drivers of cost-effectiveness included the cost and performance (sensitivity and specificity) of the AI tool. This study suggests that an AI-based approach to earlier detect HCC in cirrhotic patients can be cost-effective. By incorporating cost-effective AI-based approaches in clinical practice, patient outcomes and healthcare efficiency are improved.

27 October 2017 in European Radiology Experimental
Verified
Journal Article
Open access
PDF file
JCJeroen Cant
Jeroen Cant
ASAnnemie Snoeckx
Annemie Snoeckx
GBGert Behiels
Gert Behiels
PPPaul Maria R. Parizel
Paul Maria R. Parizel
Jan SijbersJan Sijbers
Jan Sijbers
Portable bedside chest X-ray (CXR) is an important and frequently used tool in the intensive care unit (ICU). Unfortunately, the diagnostic value of portable CXR is often low due to technical limitations and suboptimal patient positioning. Additionally, abnormalities in the chest may be hidden on the projection image by overlapping anatomy and devices such as endotracheal tubes, lines and catheters. Digital tomosynthesis (DTS) can solve the problem of anatomical overlap. In DTS, several low-dose X-ray images from different angles are acquired and subsequently used by a reconstruction algorithm to compute section images along planes parallel to the detector. However, a portable device to be used for portable bedside chest DTS is not on the market yet. In this work, we discuss modifications to a portable X-ray device to enable portable DTS and illustrate the potential of portable DTS to improve the diagnostic value of bedside CXR in the ICU. A simulation, based on computed tomography scans, is presented. Our experiments comparing portable DTS with conventional bedside CXR showed a substantially improved detection of pneumothorax and other abnormalities.

7 October 2022 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
MLMaria Gabriela Figueiro Longo
Maria Gabriela Figueiro Longo
PVPieter Vuylsteke
Pieter Vuylsteke
CTCan Ozan Tan
Can Ozan Tan
JSJoris A.M. Soons
Joris A.M. Soons
LALaura Avery
Laura Avery
RGRajiv Gupta
Rajiv Gupta

29 November 2019 in Cancer Imaging
Verified
Journal Article
Open access
PDF file
ASAnnemiek Snoeckx
Annemiek Snoeckx
JCJeroen Cant
Jeroen Cant
CFCaro Franck
Caro Franck
ELElisa Luyckx
Elisa Luyckx
KCKen Carpentier
Ken Carpentier
PPPaul Maria R. Parizel
Paul Maria R. Parizel
Purpose: A newly developed image processing technique fuses conventional windows into a single ‘All-In-One’ (AIO) window. This study aims to evaluate variability of CT measurement of lesions in thoracic oncology patients on this novel AIO-window. Methods: Six radiologists with different levels of expertise measured 368 lesions of various size, origin and sharpness. All lesions were measured twice on the AIO-window and twice on the conventional window settings. Intraclass correlation coefficients and Bland-Altman plots were used to assess intra- and interobserver variability. Results: Overall intra-observer agreement for lesion diameters on the AIO-window and conventional window settings was 0.986 (95% Confidence interval (CI): 0.983–0.989) and 0.991 (95% CI 0.989–0.993) respectively. For interobserver agreement this was 0.982 (95% CI 0.979–0.985) (AIO) and 0.979 (95% CI 0.957–0.982) (conventional). For both the AIO and conventional windows, intra- and interobserver agreement were dependent on size, sharpness and reader experience. Measurement variability decreased with increasing lesion size. Regarding sharpness, inter- and intra-observer agreement ranged from 0.986–0.989 (AIO) and 0.985–0.992 (conventional) for well-defined lesions and from 0.978–0.983 (AIO) and 0.974–0.991 (conventional) for ill-defined lesions. Conclusions: Lesion diameters were consistently smaller on the AIO-window compared to conventional window settings. Overall intra- and interobserver variability rates were similar for the AIO-window and conventional window settings. We conclude that the AIO-window offers a reliable and reproducible alternative for measurement of thoracic lesions.

17 January 2023 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
ABAstrid Berg
Astrid Berg
EVEva Vandersmissen
Eva Vandersmissen
MWMaria Wimmer
Maria Wimmer
DMDavid Major
David Major
TNTheresa Neubauer
Theresa Neubauer
KBKatja Bühler
Katja Bühler

31 May 2024 in Acute and Critical Care
Verified
Journal Article
Open access
PDF file
SWShauni Wellekens
Shauni Wellekens
NBNico Buls
Nico Buls
JMJohan De Mey
Johan De Mey
VNVincent Van Nieuwenhove
Vincent Van Nieuwenhove
JCJeroen Cant
Jeroen Cant
JJJoop Jonckheer
Joop Jonckheer
Portable chest radiography is a valuable tool in the intensive care unit. However, the supine position causes superposition of anatomical structures resulting in less reliable detection of certain abnormalities. Recently, a portable digital tomosynthesis (pDTS) prototype with a modified motorized x-ray device was developed. We aimed to compare the diagnostic value of pDTS to standard bedside chest radiography in the diagnosis of a posterior pneumothorax. A modified motorized x-ray device was developed to perform 15 radiographic projections while translating the x-ray tube 25 cm (10 cm ramp up and 15 cm during x-ray exposure) with a total radiation dose of 0.54 mSv. This new technique of pDTS was performed in addition to standard bedside chest x-ray in a patient with a confirmed posterior hydropneumothorax. The images were compared with the standard bedside chest x-ray and computed tomography (CT) images by two experienced radiologists. The posterior hydropneumothorax previously identified with CT was visible on tomosynthesis images but not with standard bedside imaging. Combining the digital tomosynthesis technique with the portable x-ray machine could increase the diagnostic value of bedside chest radiography for the diagnosis of posterior pneumothoraces while avoiding intrahospital transport and limiting radiation exposure compared to CT.